BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.645
-0.035 (-2.08%)
Jan 29, 2026, 11:35 AM EST - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $35.98 million as of January 29, 2026. Its market cap has increased by 88.87% in one year.
Market Cap
35.98M
Enterprise Value
109.85M
1-Year Change
88.87%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $35.98M, a decrease of -79.15%. That is a compound annual growth rate of -18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 36.74M | 5.00% |
| Dec 31, 2025 | 34.99M | 88.57% |
| Dec 31, 2024 | 18.56M | -78.51% |
| Dec 29, 2023 | 86.35M | -85.65% |
| Dec 30, 2022 | 601.94M | 5.82% |
| Dec 31, 2021 | 568.84M | -49.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Oncology | 93.28M |
| Assertio Holdings | 76.81M |
| Cumberland Pharmaceuticals | 56.09M |
| InterCure | 52.01M |
| Zhengye Biotechnology Holding | 48.81M |
| Talphera | 46.61M |
| Rockwell Medical | 42.95M |
| SCYNEXIS | 33.32M |